specifically it is used to treat multi drug resistant tuberculosis mdr tb along with other medications for tuberculosis it is used by mouth common side effects include nausea joint pains headaches and chest pain serious side effects include qt prolongation liver dysfunction and an increased risk of death while harm during pregnancy has not been found it has not been well studied in this population it is in the diarylquinoline antimycobacterial class of medications it works by blocking the ability of m tuberculosis to make adenosine 5 triphosphate atp bedaquiline was approved for medical use in the united states in 2012 it is on the world health organization s list of essential medicines the most effective and safe medicines needed in a health system the cost for six months is approximately us 900 in low income countries us 3 000 in middle income countries and us 30 000 in high income countries its use was approved in december 2012 by the u s food and drug administration fda for use in tuberculosis tb treatment as part of a fast track accelerated approval for use only in cases of multidrug resistant tuberculosis and the more resistant extensively drug resistant tuberculosis bedaquiline